Moderna, Inc. announced that its Annual Meeting of Shareholders will be held virtually on May 6, 2024. Shareholders of record as of March 7, 2024, are entitled to vote on several key proposals, including the election of three Class III directors, advisory approval of executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2024. Additionally, shareholders will vote on amendments to Moderna's Certificate of Incorporation to provide shareholders the right to call a special meeting and to reflect new Delaware law provisions allowing for officer exculpation. The Board of Directors recommends voting FOR all proposals. Preliminary voting results will be announced at the meeting, with final results to be filed with the SEC within four business days.

Moderna, Inc. announced that its Annual Meeting of Shareholders will be held virtually on May 6, 2024. Shareholders of record as of March 7, 2024, are entitled to vote on several key proposals, including the election of three Class III directors, advisory approval of executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2024. Additionally, shareholders will vote on amendments to Moderna's Certificate of Incorporation to provide shareholders the right to call a special meeting and to reflect new Delaware law provisions allowing for officer exculpation. The Board of Directors recommends voting FOR all proposals. Preliminary voting results will be announced at the meeting, with final results to be filed with the SEC within four business days.